CLINICAL_TRIALS
withdrawal
· 2026-04-09
Clinical Trial Update: Vatiquinone Expanded Access Protocol
Summary
The expanded access protocol for vatiquinone in mitochondrial disease is no longer available.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medical University of South Carolina | Conditions: Mitochondrial Disease | Status: NO_LONGER_AVAILABLE